Map Will Track Pancreatic Cancer Researchers, Studies, Funding Opportunities
On Nov. 8, NCI and the Pancreatic Action Network (PanCAN) launched the first phase of the Pancreatic Cancer Research Map (www.cancermap.org/pancreatic). "The map will enable the community to find and search a comprehensive list of research projects and open clinical trials relevant to cancer. It also aims to facilitate collaboration among pancreatic cancer researchers," said Cherie Nichols, who has headed the activity in NCI's Office of Science Planning and Assessment. In phase 1, NCI-sponsored projects, funding opportunities, and a database of pancreatic cancer investigators will be available. Similar information for nonprofit and private organizations will be added to the database during the next phase, which is expected to begin in the near future. Patients and their families can use the Web site to see what studies are underway and where investigations of interest to them are located.
"Pancreatic cancer is the fourth leading cause of cancer death in the United States," said Paula Kim, co-founder of PanCAN. "More than 31,000 people are diagnosed with pancreatic cancer every year, and it continues to be the cancer with the highest mortality. The map will enable researchers to find and search a comprehensive list of studies and projects relevant to pancreatic cancer."
Alliance for Nanotechnology in Cancer Moves Forward
The next nanotechnology symposium will be held Feb. 22, 2005 at the Lombardi Comprehensive Cancer Center in Washington, D.C.
President's Cancer Panel Meets in Houston
Participants also noted the existing imbalance between the numbers of researchers in basic science and translational research, and suggested the development of a national strategy to shift the emphasis between these disciplines, including transforming individual and team reward structures. They noted that this will also require a cultural shift and reevaluation of grant review criteria and assessments made by review committee members. The Specialized Programs of Research Excellence program was mentioned as a successful model for structuring translational research efforts.
Cancer.gov Offers Direct Links to NIH Roadmap Funding Opportunities
Launched in September 2003 by NIH Director Dr. Elias Zerhouni, the NIH Roadmap is a series of far-reaching initiatives designed to transform the nation's medical research capabilities and speed the movement of research discoveries from the bench to the bedside. It provides a framework of the priorities that NIH must address to optimize its entire research portfolio and lays out a vision for a more efficient and productive system of medical research.
To view the current NIH Roadmap funding opportunities, go to: http://nihroadmap.nih.gov/grants/index.asp